Materias dentro de su búsqueda.
Materias dentro de su búsqueda.
-
401“…We describe a 64-year-old Caucasian female with a history of Raynaud's disease, hand arthritis, photosensitivity, Sjogren's syndrome and leukocytoclastic vasculitis who presented with progressively worsening fingertip necrosis that began three days after receiving a first dose of Pfizer–BioNTech COVID-19 RNA vaccine. Our workup revealed cryoglobulinemia, hypocomplementemia, elevated antinuclear antibodies (ANA) and IgM antiphospholipid autoantibodies (aPL) directed against phosphatidylserine (aPL-PS), suggesting a diagnosis of systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS). …”
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
402por Tuong, Linh-An C, Capucilli, Peter, Staicu, Mary, Ramsey, Allison, Walsh, Edward E, Shahzad Mustafa, S“…Two mRNA coronavirus disease 2019 (COVID-19) vaccines, Moderna and Pfizer-BioNTech, require 2 doses for maximum efficacy. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
403“…Casos de trombocitopenia imune associados à imunização contra SARS-CoV-2, incluindo a vacina BNT16B2b2 mRNA da Pfizer, foram descritos. RELATO DE CASO: Um homem de 38 anos, previamente hígido e que não fazia uso de qualquer medicamento, recebeu a vacina PfizerBioNTech BNT16B2b2 mRNA. …”
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
404por Hai, Josephine, Shawa, Harrison, Kim-Lim, Penelope, Wang, Jenny Z., Vy, Michelle, Fung, Maxwell A., Sood, Apra, Tartar, Danielle M.Enlace del recurso
Publicado 2021
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
405
-
406por Bouattour, Nadia, Hdiji, Olfa, Sakka, Salma, Fakhfakh, Emna, Moalla, Khadija, Daoud, Sawsan, Farhat, Nouha, Damak, Mariem, Mhiri, Chokri“…CASE PRESENTATION: We present a case of a 67-year-old man who presented 7 days following his first dose of Pfizer-BioNTech COVID-19 vaccine a rapidly progressive ascending muscle weakness. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
407
-
408por Malayala, Srikrishna V, Papudesi, Bhavani N, Sharma, Rishika, Vusqa, Urwat T, Raza, Ambreen“…So far no such cases have been reported after the third (booster) dose of the Pfizer-Biontech vaccine. With this case report, we present the case of the patient and discuss the literature related to vaccine-induced thrombocytopenia.…”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
409por Alamer, Edrous, Alhazmi, Abdulaziz, Qasir, Naaif A., Alamer, Rahaf, Areeshi, Halima, Gohal, Gassem, Qadri, Marwa, Hashem, Anwar M., Algaissi, Abdullah“…In this study, we aimed to investigate the early side effects of Pfizer-BioNTech (BNT162b2) mRNA vaccine in children between 12–18 years old in Saudi Arabia. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
410
-
411por Saciuk, Yaki, Kertes, Jennifer, Mandel, Micha, Hemo, Beatriz, Shamir Stein, Naama, Ekka Zohar, Anat“…Development of an effective vaccine against Covid-19 is crucial to reducing infection. mRNA BNT162b2, developed and manufactured by Pfizer-BioNTech, was one of the first FDA-approved vaccinations reporting high efficacy (95%) and minimal side effects. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
412por Whitaker, Heather J., Tsang, Ruby S.M., Byford, Rachel, Andrews, Nick J., Sherlock, Julian, Sebastian Pillai, Praveen, Williams, John, Button, Elizabeth, Campbell, Helen, Sinnathamby, Mary, Victor, William, Anand, Sneha, Linley, Ezra, Hewson, Jacqueline, DArchangelo, Silvia, Otter, Ashley D., Ellis, Joanna, Hobbs, Richard F.D., Howsam, Gary, Zambon, Maria, Ramsay, Mary, Brown, Kevin E., de Lusignan, Simon, Amirthalingam, Gayatri, Lopez Bernal, Jamie“…Reduced vaccine effectiveness against clinical disease was also noted in the immunosuppressed group; after a second dose, effectiveness was moderate (Pfizer: 59.6%, 95%CI 18.0–80.1%; AstraZeneca 60.0%, 95%CI -63.6–90.2%). …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
413
-
414por Kolarić, Branko, Ambriović-Ristov, Andreja, Tabain, Irena, Vilibić-Čavlek, Tatjana“…All participants received two doses of BioNTech/Pfizer COVID-19 and had no previously detected SARS-CoV-2 infection. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
415por Lai, Francisco Tsz Tsun, Leung, Miriam Tim Yin, Chan, Edward Wai Wa, Huang, Lei, Lau, Lauren Ka Wun, Peng, Kuan, Leung, Janice Ching Nam, Fan, Min, Chen, Kailin, Lum, Dawn Hei, Li, Xue, Chui, Celine Sze Ling, Wan, Eric Yuk Fai, Wong, Carlos King Ho, Lam, Edwin Fung Shing, Cheung, Terence Yung Yan, Cowling, Benjamin John, Wong, Ian Chi Kei, Chan, Esther Wai Yin“…This study aimed to compare self-reported post-vaccination adverse reactions between CoronaVac and Comirnaty (Pfizer-BioNTech). METHODS: We adopted a prospective cohort study design using online surveys from the day of first-dose vaccination with intensive follow-up through two weeks after the second dose (11 time points). …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
416
-
417por Cortés-Sarabia, Karen, Gutiérrez-Torres, Mayralina, Mendoza-Renteria, Escarlet Maleny, Leyva-Vázquez, Marco Antonio, Vences-Velázquez, Amalia, Hernández-Sotelo, Daniel, Beltrán-Anaya, Fredy Omar, Del Moral-Hernández, Oscar, Illades-Aguiar, Berenice“…The BNT162b2 Pfizer/BioNTech vaccine was the first emergency approved vaccine during the COVID-19 pandemic. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
418“…A 52‐year‐old female developed ACC after 8 h of receiving a 3rd dose of the Pfizer‐BioNTech COVID‐19 vaccination. The symptoms subsided completely with conservative treatment for 12 days, and the ultrasound and laboratory findings went back to normal.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
419por Algaissi, Abdullah, Alamer, Edrous, Jeraiby, Mohammed, Alomaish, Abeer, Elrhima, Omer, Qumayi, Sultan, Qasir, Naaif A., Areeshi, Halima, Masmali, Asma, Alhazmi, Abdulaziz“…OBJECTIVES: To evaluate hematological parameters and thrombotic profiles of healthy individuals who received Pfizer-BioNTech (BNT162b2) vaccines in Saudi Arabia. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
420“…Initially, mainstream news linked mostly “Pfizer” with side effects (e.g. “allergy”, “reaction”, “fever”). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto